Biren Amin
Stock Analyst at Jefferies
(1.29)
# 2,532
Out of 4,435 analysts
17
Total ratings
50%
Success rate
3.35%
Average return
Main Sectors:
Top Industries:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZNTL Zentalis Pharmaceuticals | Maintains: Buy | $120 → $70 | $11.79 | +493.72% | 2 | May 19, 2023 | |
| BCAB BioAtla | Initiates: Buy | n/a | $2.46 | - | 1 | Jan 11, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | n/a | $4.03 | - | 1 | Oct 30, 2020 | |
| TSHA Taysha Gene Therapies | Initiates: Buy | n/a | $3.09 | - | 1 | Oct 19, 2020 | |
| KALA Kala Pharmaceuticals | Downgrades: Hold | n/a | $6.63 | - | 1 | Sep 14, 2020 | |
| IMTX Immatics | Initiates: Buy | n/a | $10.94 | - | 1 | Jul 24, 2020 | |
| CTMX CytomX Therapeutics | Downgrades: Hold | n/a | $1.92 | - | 1 | Jun 1, 2020 | |
| CALA Calithera Biosciences | Initiates: Buy | n/a | $0.02 | - | 1 | Mar 27, 2020 | |
| REGN Regeneron Pharmaceuticals | Upgrades: Buy | n/a | $987.27 | - | 1 | Feb 25, 2020 | |
| ADXS Ayala Pharmaceuticals | Downgrades: Hold | n/a | $0.30 | - | 1 | Jun 13, 2018 | |
| BLUE bluebird bio | Upgrades: Buy | n/a | $1.03 | - | 2 | Dec 11, 2017 | |
| ANAB AnaptysBio | Initiates: Buy | n/a | $25.01 | - | 1 | Nov 9, 2017 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | n/a | $141.65 | - | 1 | Oct 3, 2017 | |
| VRTX Vertex Pharmaceuticals | Initiates: Buy | n/a | $445.87 | - | 1 | Jul 11, 2017 | |
| NERV Minerva Neurosciences | Initiates: Buy | n/a | $2.48 | - | 1 | Mar 6, 2017 |
Zentalis Pharmaceuticals
May 19, 2023
Maintains: Buy
Price Target: $120 → $70
Current: $11.79
Upside: +493.72%
BioAtla
Jan 11, 2021
Initiates: Buy
Price Target: n/a
Current: $2.46
Upside: -
Aldeyra Therapeutics
Oct 30, 2020
Initiates: Buy
Price Target: n/a
Current: $4.03
Upside: -
Taysha Gene Therapies
Oct 19, 2020
Initiates: Buy
Price Target: n/a
Current: $3.09
Upside: -
Kala Pharmaceuticals
Sep 14, 2020
Downgrades: Hold
Price Target: n/a
Current: $6.63
Upside: -
Immatics
Jul 24, 2020
Initiates: Buy
Price Target: n/a
Current: $10.94
Upside: -
CytomX Therapeutics
Jun 1, 2020
Downgrades: Hold
Price Target: n/a
Current: $1.92
Upside: -
Calithera Biosciences
Mar 27, 2020
Initiates: Buy
Price Target: n/a
Current: $0.02
Upside: -
Regeneron Pharmaceuticals
Feb 25, 2020
Upgrades: Buy
Price Target: n/a
Current: $987.27
Upside: -
Ayala Pharmaceuticals
Jun 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $0.30
Upside: -
bluebird bio
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.03
Upside: -
AnaptysBio
Nov 9, 2017
Initiates: Buy
Price Target: n/a
Current: $25.01
Upside: -
Neurocrine Biosciences
Oct 3, 2017
Maintains: Buy
Price Target: n/a
Current: $141.65
Upside: -
Vertex Pharmaceuticals
Jul 11, 2017
Initiates: Buy
Price Target: n/a
Current: $445.87
Upside: -
Minerva Neurosciences
Mar 6, 2017
Initiates: Buy
Price Target: n/a
Current: $2.48
Upside: -